The Google cofounder has donated more than $1.5 billion to Parkinson’s research. Now, as he takes on autism, he’s also ...

We spend billions searching for the cures to chronic illnesses while neglecting research that could make the daily lives of ...

The class’ availability online through Zoom is a major feature. With how Parkinson’s can affect movement, and the ability to travel not always guaranteed, having access to pivotal information ...

Sen. Will Parkinson introduced a bill that seeks to provide emergency contraception or “morning-after pill” to rape survivors as an option. It would still be up to the rape survivors to decide ...

Treatment with exenatide, a GLP-1 receptor agonist, was comparable to placebo in slowing the rate of Parkinson’s disease ...

What you need to know about the new rulesPatients with Parkinson's disease get zero benefit from taking a skinny jab despite ...

The GLP-1 drug, exenatide, has no positive impact on the movement, symptoms or brain imaging of people with Parkinson's, finds a new study led by UCL researchers.

The GLP-1 drug, exenatide, has no positive impact on the movement, symptoms or brain imaging of people with Parkinson's, ...

The FDA approved an apomorphine hydrochloride infusion device (Onapgo) to treat motor fluctuations in adults with advanced ...

The U.S. Food and Drug Administration has approved Supernus Pharmaceuticals' drug-device combination to treat ...

Elliot Lee says the carrot of playing at Wembley will ensure Wrexham field a strong side when they travel to Port Vale in the ...